Rush University Medical Center is the first hospital in Chicago to use a new technology that enables specially trained physicians to use a single stitch to close an opening between the upper chambers of the heart.
Dr. Annabelle Volgman, director of the Rush Heart Center for Women, is one of three cardiologists and one of four of the nation’s medical and political leaders to be recognized by WomenHeart: The National Coalition for Women with Heart Disease in Washington. WomenHeart awarded Volgman the 2019 Wenger Award for Excellence in Medical Innovation.
Amazing new devices and technology are transforming cardiac care. Doctors at each of the Rush hospitals discuss these innovations and how they benefit patients.
Rush University Medical Center is the first hospital in Illinois to use a new device that helps patients to get back on their feet in as little as two hours — rather than the typical recovery period of 6 to 10 hours — after cardiac electrophysiology procedures such as cardiac ablation for atrial fibrillation.
Using a new visually guided laser balloon device, cardiologists at Rush University Medical Center are able to more precisely treat cardiac arrhythmias causing atrial fibrillation.
Rush University Medical Center cardiologists providing comprehensive general and interventional cardiology services at Chicago’s Mercy Hospital and Medical Center will mean the best in cardiac care is available to a greater number of people.
A new study reveals that South Asian-Americans are more likely to die of heart conditions caused by atherosclerosis, such as heart attacks and strokes, than East Asians and non-Hispanic whites in the U.S.
At a time when new guidelines mean far more people are thought to have high blood pressure, the CDC has honored Rush for controlling it in patients.
Rush Oak Park Hospital has launched a cardiac rehabilitation program to help people with cardiovascular disease lead healthier, more active lives.
Rush University Medical Center is offering a new, implantable cardiac device to reduce the risk of stroke in patients with atrial fibrillation, providing an alternative to the long-term use of blood thinners.